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Introduction 
 
Alcohol and substance use disorders (referred to hereafter as SUDs) are known to be 
associated with various negative health outcomes including somatic health problems 
(e.g. Dela Cruz et al., 2016; Rehm et al., 2017), depression (e.g. Grant et al., 2004; 
Pirkola et al., 2005) and impaired Quality of Life (QoL) (Levola, Aalto, Holopainen, 
Cieza, & Pitkanen, 2014; e.g. Vederhus, Pripp, & Clausen, 2016). Somatic health 
problems related to SUDs may be the direct result of exposure to alcohol and other 
drugs or they may be the end result of high-risk behaviour commonly associated with 
SUDs. Individuals with SUDs may have problems with seeking adequate medical help 
for their somatic health problems and they are also more likely to have impaired 
treatment adherence (Catz, Heckman, Kochman, & DiMarco, 2001; Kunz, 1997; Levola et 
al., 2014).  
Self-rated health has been shown to be a good predictor of future health and 
functioning as well as an important indicator of QoL (Becchetti, Bachelet, & Riccardini, 
2017; Benyamini et al., 2014; Hillen, Davies, Rudd, Kieselbach, & Wolfe, 2003; Idler & 
Kasl, 1995). A strong association has been reported in several studies between self-rated 
health and mortality (Idler & Kasl, 1991; Sundquist & Johansson, 1997; Thong et al., 
2008). Despite the multiple health problems that individuals with SUDs experience, not 
  
much is known about how these individuals themselves view their own health.  
Depression and symptoms thereof are extremely common among individuals 
with SUDs (Grant et al., 2004; Pirkola et al., 2005). Various explanations of co-
occurring psychiatric and substance related disorders have been offered. Substance use 
can be the direct cause of psychiatric symptoms or it can exacerbate existing conditions. 
In some instances substance use may be the result of an ill-advised attempt to “self-
medicate” psychiatric distress. According to recent research, substance use would 
appear to predispose to an increased risk of depression - at least in the case of alcohol -  
and the “self-medication hypothesis” has met criticism (Fergusson, Boden, & Horwood, 
2009; Lembke, 2012).  
Depression has been linked to worse self-rated health (Bustos-Vazquez, 
Fernandez-Nino, & Astudillo-Garcia, 2017; Mulsant, Ganguli, & Seaberg, 1997) and 
impaired QoL (Papakostas et al., 2004) in a number of studies. Previous research has 
shown that depression and somatic health concerns are common among individuals with 
SUDs, however, to the authors’ knowledge, few studies have utilized self-rated health in 
the context of SUDs and no studies to date that have analyzed the association between 
symptoms of depression and self-rated health among individuals with SUDs. 
The aims of this study were 1) to assess self-rated health among individuals 
undergoing inpatient treatment for SUDs i.e. describe how they perceived their health 
status and 2) to analyze how having symptoms of depression affected perceptions of 
health status and QoL among these individuals. 
  
 
Methods 
 
The data comprised a convenience sample of eighty inpatients at Järvenpää Addiction 
Hospital with a diagnosis of alcohol or substance dependence according to the 
International Classification of Diseases, 10th revision (ICD-10) (The World Health 
Organization, 2016). Data were collected within the scope of the PARADISE project in 
2012 (Cieza et al., 2015). The study protocol and all documents were approved by the 
A-Clinic Foundation’s ethical committee for treatment and research. 
The study protocol included a clinical interview and validated questionnaires. 
Socio-demographic variables including age, gender, education, working status and main 
substance of use (alcohol vs. other), duration of dependence and smoking status were 
obtained via interview. 
A general self-assessment of one’s health (SAH) was obtained using a single-
item scale ranging from very poor (1) to very good (5) that has been widely used as a 
measure of subjective health (Bailis, Segall, & Chipperfield, 2003; Smith & Goldman, 
2011). Comorbidities were reported using the Self-Administered Comorbidities 
Questionnaire (SCQ), including a sum score of twelve common conditions (heart 
disease, high blood pressure, lung disease, diabetes, ulcer or stomach disease, kidney 
disease, liver disease, anaemia or another blood disease, cancer, depression, 
osteoarthritis or degenerative arthritis, back pain, rheumatoid arthritis, alcohol or other 
substance dependence) and the option of adding up to three conditions (Sangha, Stucki, 
Liang, Fossel, & Katz, 2003). Each condition in the SCQ is rated on the basis of severity 
from 0 to 3 based on whether the respondent has had the condition on the past year (Do 
  
you have ..? yes 1 pt), has sought medical attention for it (Do you receive treatment for 
it? yes 2 pts) and whether it has affected their functioning (Does it limit your activities? 
yes 3 pts). These three questions were also analyzed independently of each other as 
dummy variables. Additionally, Quality of Life was assessed using the 8-item European 
Health Interview Survey - Quality of Life (EUROHIS-QOL-8) (Schmidt, Muhlan, & 
Power, 2006). All eight items are scored from one to five (range 8 to 40) with higher 
scores indicating better QoL. 
The Beck Depression Inventory (BDI-II) was used to evaluate symptoms of 
depression. It consists of 21 questions with four response options each (0 to 3 pts per 
question, range 0 to 63 pts) with a higher score indicating more severe symptoms of 
depression (Beck, Steer, Ball, & Ranieri, 1996). For the purpose of this study and 
following the guidelines of Beck et al. (1996), participants were categorized into non-
depressed if they received a BDI-II score of 0 to 19 pts and into depressed if they 
reported ≥20 pts. Information regarding diagnoses of major depression or bipolar 
disorder were also obtained. 
 
Statistical analyses 
 
Correlations between self-rated health (SAH), comorbidities (SCQ), QoL (EUROHIS-
QoL-8) and severity of depression (BDI-II) as continuous variables were analyzed using 
Pearson’s correlation coefficient. Age and duration of dependence were categorized 
with the cut-off of 40 years (age) and 10 years (duration of dependence). The rest of the 
socio-economic variables (male vs. female gender, higher vs. lower education, working 
vs. not working) and substance related variables (alcohol vs. other, daily smoking vs. no 
  
daily smoking) were also categorical. The mean scores of the SAH, SCQ, EUROHIS-
QoL-8 and BDI-II measures with 95% confidence interval were reported for each 
category of socio-economic and substance related variable and the differences in the 
mean scores were studied using one-way ANOVA (F-test). 
Separate multivariate linear regression models (enter) were then calculated for 
self-rated health, comorbidities and QoL as the independent variables in order to allow 
for adjustment for potential confounders. The BDI-II score was used in the multivariate 
models as a continuous variable in order to ascertain whether symptoms of depression 
were linearly associated with the independent variables. Separate models were created 
due to the intercorrelation between self-rated health, comorbidities, QoL and depression 
symptom severity (Table 1). 
Listwise deletion was applied due to the assumption that data was missing 
completely at random (MCAR). Listwise deletion resulted in 17.5% (n = 66/80) data 
loss. However, because the assumption of data MCAR is difficult to determine, the final 
analyses were also performed using multiple imputation to account for missing data in 
order to ascertain that listwise deletion did not bias the main results. After screening the 
data and determining that data were missing in an arbitrary pattern, multiple imputation 
was performed with the chained equation –method, specifically the iterative MCMC-
algorithm which is the default for arbitrarily missing data in SPSS. The five imputed 
datasets with a maximum ten iterations were pooled for analyses. Imputation was 
performed if missing data were observed for socio-demographic and SUD-related 
variables, depression as well as the variables regarding self-rated health, comorbidities 
and QoL. Missing data were observed as follows: BDI-II 10.0%, EUROHIS-QoL-8 
7.5%, SAH 0.0%, SCQ 0.0%, socio-demographic variables 0.0%, substance use related 
variables 0.0%. 
  
Results were considered statistically significant at p < 0.05. All analyses were 
performed with SPSS version 22.  
 
Results 
 
The mean age of the 80 participants was 39.6 (SD 13.2) and one third were women 
(Table 2). All participants had a diagnosis of alcohol or substance dependence, half 
were in treatment primarily due to alcohol use and the other half because of alcohol 
and/or other substance use. A third of the participants had no more than a primary 
school education. Being outside of the workforce due to disability or unemployment 
was common. Three out of four participants were smokers.  
Morbidity according to the SCQ is displayed in Figure 1, where conditions 
reported by at least 10% (n=8) of participants are included. Back pain, high blood 
pressure and liver disease were the most commonly reported somatic comorbidities. A 
little over half of participants with self-reported high-blood pressure reported having 
received treatment for it and quite a small number of participants reported having 
received treatment for back pain or liver disease. 
Alcohol vs. other dependence 
Participants with primary alcohol dependence were statistically significantly older than 
participants with other dependence (mean 46.8 yrs vs. 32.3 yrs; p < 0.001), had more 
often completed secondary education (alc n = 30 vs. other n = 19; p < 0.05) and had 
fewer comorbid dependences of other substances (mean 1.2 vs. 1.7; p < 0.001). There 
was no statistically significant difference in gender (alc men n = 28 vs. other n = 22; p = 
0.249), unemployment (alc n = 32 vs. other n = 30; p = 0.790), disease duration (mean 
  
alc 11.9 yrs vs. other 12.45 yrs; p = 0.749) or daily smoking (alc n = 28 vs. other n = 34; 
p = 0.180) between primarily alcohol dependent participants and those with other 
dependence.  
Perceived health status and QoL 
Self-rated health was reported to be moderate (mean 3.2; SD 0.8). The mean SCQ-score 
for comorbidities was 8.8. (SD 4.8) and the mean EUROHIS-QoL-8 –score for quality 
of life was 25.3 (SD 6.2). The mean scores for symptoms of depression, self-rated 
health, comorbidities and QoL stratified by socio-demographic and SUD related 
variables are presented in Table 2.  Self-rated health and QoL were poorer among men 
than among women. Higher age and longer duration of dependence were associated 
with more reported comorbidities. There were no statistically significant differences 
between participants with regard to other variables, e.g. educational level, employment 
status or primary alcohol dependence vs. other dependence.  
 
Symptoms of depression 
Of the 80 participants, 72 had filled out the BDI-II. A large proportion of the 
participants (72.2%) reported at least mild (>13) depressive symptoms and mean BDI-II 
scores were quite high (22.5; SD 12.5). Every other participant had a BDI-II score of 
≥20 i.e. were categorized as depressed for the purposes of our study. Of all participants, 
15.0% (n=12) had a diagnosis of unipolar major depression and an additional 12.5% 
(n=10) a diagnosis of bipolar disorder.  Those with a diagnosis of major depression or 
bipolar disorder reported more severe symptoms of depression symptoms (mean 30.8; 
SD 10.6) than other participants [mean 19.4; SD 11.8). 
 
  
Older age, being more educated and longer duration of SUD were associated 
with being categorized as depressed according to BDI-II scores (Table 2). Depressed 
participants rated their health to be statistically significantly poorer and reported more 
comorbidities than non-depressed participants. Depressed participants also reported 
statistically significantly worse QoL than did non-depressed participants. Severity of 
depression (BDI-II) was correlated with worse self-rated health, more comorbidities 
(SCQ), and poorer QoL (Table 1). 
Multivariate analyses 
The variables entered in the multivariate linear regression analyses were age, gender, 
level of education, working status, type and duration of SUD, smoking status and 
severity of depressive symptoms. Of all the variables in the multivariate analyses, more 
severe symptoms of depression were associated with poorer self-rated health (Table 3). 
More severe symptoms of depression were also statistically significantly associated 
with more self-reported comorbidities, as was longer duration of SUD. More severe 
symptoms of depression and male gender were associated with impaired QoL in the 
multivariate analyses. Thus, the statistically significant bivariate correlations (Table 1) 
between symptoms of depression and self-rated health, comorbidities and QoL were 
present even after adjusting for cofounders in the multivariate models (Table 3). 
 
Discussion 
 
The patients undergoing inpatient treatment for substance and alcohol dependence 
reported various somatic comorbidities and their self-rated health was moderate. 
Symptoms of depression were very common and half of the participants received a 
  
score of 20 or more corresponding to moderate or severe symptoms of depression 
according to Beck et al. (1996). More severe symptoms of depression were associated 
with poorer self-rated health, more comorbidities and poorer QoL after adjusting for 
potential confounders such as age. Participants with alcohol dependence were older and 
more highly educated compared to participants with substance dependence, but did not 
differ with regard to perceived health status, QoL or symptoms of depression.  
Multimorbidity is common in depression (Read, Sharpe, Modini, & Dear, 2017) 
and symptoms of depression have been reported to be associated with psychosocial 
difficulties (Pitkänen, Levola, de la Fuente, & Cabello, 2018). In this study, participants 
categorized as depressed had significantly poorer self-assessed health, more somatic 
comorbidities and poorer QoL than those categorized as non-depressed. The association 
of depressive symptoms and self-assessed health, somatic comorbidities and QoL 
persisted after adjusting for confounders. These findings are consistent with previous 
literature. While it is possible that somatic illness cumulates on those with comorbid 
depression, it is also possible that depression negatively affects an individual’s 
perception of his or her health. Depression may also impair an individual’s ability to 
care for oneself and seek adequate treatment for somatic complaints. 
Symptoms of depression were extremely common among the participants in this 
study. While the BDI-II is not a diagnostic instrument, half of the participants reported 
moderate or severe symptoms of depression and were categorized into depressed for the 
purposes of this study. Both primary (i.e. independent) and secondary (i.e. substance 
induced) mood disorders are highly prevalent among individuals with SUDs (Hasin, 
Stinson, Ogburn, & Grant, 2007) which is reflected in the results of this study. 
The multivariate regression models in this study showed that longer duration of 
  
SUDs was associated with somatic comorbidities irrespective of age. This suggests that 
the longer the duration of substance use disorder, the more harm is afflicted on a 
person’s health. Accordingly, it has been shown e.g. in the case of hepatitis C - a 
common complication of injecting drug use – that its prevalence rises with the duration 
of injecting drug use (Varjonen, 2015). Participants reported that their comorbidities 
were often undertreated. This finding is unfortunately in line with previous research, 
which has shown that persons with psychiatric illness and substance use disorders 
increased mortality (Lumme, Pirkola, Manderbacka, & Keskimaki, 2016). This increase 
in mortality may be explained by problems in treatment seeking and treatment 
adherence, but also inadequate treatment received for treatable somatic illness due to 
stigma (Levola et al., 2014; Sullivan et al., 2015). 
Several studies have shown alcohol and substance use disorders to be associated 
with impaired QoL (e.g. Donovan, Mattson, Cisler, Longabaugh, & Zweben, 2005; 
Levola et al., 2014). In this study, the mean score for QoL was 25.3. According to 
previous research, mean QoL scores reported using the EUROHIS-QOL-8 among the 
general population in Europe were higher (mean 29.4) and higher still when analyzing 
Western European countries (mean 32.1) (Schmidt et al., 2006). The results of this 
study are thus in concordance with previous findings were SUDs have been associated 
with impaired QoL. Depression is also well known to be associated with impaired QoL 
(IsHak et al., 2011; Papakostas et al., 2004). According to the results of this study, 
depression was associated with impaired QoL after adjusting for socio-demographic 
variables, smoking status, as well as type and duration of SUDs.  
The results of this study are to be interpreted with some limitations. The study 
population was a convenience sample of individuals in inpatient treatment for SUDs 
  
and thus the characteristics of these participants most likely represent severe alcohol 
and substance use disorders. The generalizability of these results may thus be limited. 
The study sample was also limited in size. However, the instruments used are well 
validated and widely used which is a strength of this study. The use of data imputation 
for missing data can be considered a further strength. 
This research contributes new knowledge as to the perceived health status of 
individuals with SUDs as well as to the impact of symptoms of depression on self-
perceived health status and QoL. Individuals with SUDs have many health-related 
concerns and their QoL is impaired. Recognizing and adequately treating somatic 
complaints among individuals with SUDs should be emphasized. Symptoms of 
depression are associated with self-rated health and QoL in this population. Further 
research is needed to bridge the information gap on self-perceived and objective health 
status of individuals with SUDs as well as their interaction with depression. 
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Table 1. Intercorrelations (Pearson) of self-assessed health, comorbidities, quality of life 
and symptoms of depression. 
Table 2. Mean scores and between group differences (one-way ANOVA) for self-rated 
health, comorbidities and QoL. 
Table 3. Associations of variables with self-rated health, comorbidities and QoL in 
multivariate linear regression models. 
Figure 1. Common comorbidities (reported by more than 10% of participants) of 
inpatients with SUDs according to the Self-reported Comorbidities Questionnaire 
(SCQ). 
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Table 1. Intercorrelations (Pearson) of self-assessed health, comorbidities, quality of life and symptoms 
of depression. 
 SAH1 
n=80 
p SCQ2 
n=80 
p EUROHIS-QoL-83 
n=74 
p BDI-II4 
n=72 
p 
SAH -- -- -- -- -- -- -- -- 
SCQ -0.381 <0.001 -- -- -- -- -- -- 
EUROHIS-QoL-8 0.596 <0.001  -0.360 <0.01 -- -- -- -- 
BDI-II -0.478 <0.001 0.392 <0.01 -0.633 <0.001 -- -- 
1 single-item scale of subjective health, range 1 (very poor) to 5 (very good)  
2 Self-Administered Comorbidities Questionnaire, range 0 to 36 with higher scores indicating more comorbidities 
3 8-item quality of life scale, range 8 to 40 with higher scores indicating better QoL 
4 Beck Depression Inventory, range 0 to 63 with higher scores indicating more severe symptoms of depression 
 
  
  
Table 2. Mean scores and between group differences (one-way ANOVA) for self-rated health, comorbidities and QoL. 
 n= 
80 
SAH1 
mean  
(95% C.I.) 
F p n= 
80 
SCQ2 
mean 
(95% C.I.) 
F p n= 
74 
EUROHIS-
QoL-833 
mean 
(95% C.I.) 
F p n= 
72 
BDI-II 
mean 
(95% C.I.) 
F p 
Gender    
 
5.23 
 
 
0.025* 
   
 
2.63 0.109 
   
 
4.89 0.030* 
   
 
0.89 
 
 
0.349 
Female 30 3.47 
(3.21-3.72) 
30 7.73 
(6.23-9.24) 
29 27.24 
(25.15-29.38) 
28 20.79 
(16.12- 25.46) 
Male 50 3.06 
(2.83-3.29) 
50 9.50 
(8.06-10.94) 
45 24.04 
(22.14-25.95) 
44 23.64 
(19.74-27.53) 
Age, yrs    
 
1.92 
 
 
0.169 
   
 
6.95 
 
 
0.010* 
   
 
0.41 
 
 
0.522 
   
 
6.91 
 
 
0.011* 
<40 43 3.33 
(3.10-3.56) 
43 7.58 
(6.51-8.65) 
41 24.88 
(22.90-26.85) 
39 19.10 
(15.22-22.98) 
≥40 37 3.08 
(2.80- 3.36) 
37 10.30 
(8.42-12.17) 
33 25.82 
(23.60-28.04) 
33 26.58 
(22.30- 30.86) 
Education    
 
0.98 0.325 
   
 
0.33 
 
 
0.568 
   
 
1.45 
 
 
0.233 
   
 
1.12 
 
 
0.040* 
Primary only 31 3.32 
(3.03-3.61) 
31 8.45  
(6.80- 10.10) 
29 26.38  
(24.25-28.51) 
28 18.72  
(13.75-23.75) 
Secondary or higher 49 3.14 
(2.92-3.37) 
49 9.08  
(7.66-10.51) 
45 24.60  
(22.62-26.58) 
44 24.93  
(21.35-28.51) 
Working status    
 
3.16 0.080 
   
 
2.18 0.144 
   
 
3.56 
 
 
0.063 
   
 
1.12 
 
 
0.295 
Yes4 18 3.50 
(3.24-3.76) 
18 7.39  
(5.74-9.04) 
18 27.67  
(25.21-30.13) 
18 19.83  
(14.27-25.40) 
No5 62 3.13 
(2.92-3.34) 
62 9.26  
(7.97-10.54) 
56 24.54  
(22.81-26.26) 
54 23.43 
(19.91-26.94) 
Primary substance    
 
0.50 0.483 
   
 
0.60 0.442 
   
 
1.31 
 
 
0.256 
   
 
2.69 
 
 
0.106 
Alcohol  40 3.15 
(2.88-3.42) 
40 9.25  
(7.66-10.84) 
35 26.17  
(24.18-28.17) 
36 24.92 
(21.05-28.78) 
Other 40 3.28 
(3.03-3.52) 
40 8.43  
(6.96-9.89) 
39 24.51  
(22.39-26.64) 
36 20.14 
(15.66-24.62) 
Duration of SUD, 
yrs 
 
 
 
 
0.26 
0.615 
 
 
 
 
8.43 
 
 
0.005** 
   
 
3.30 
 
 
0.073 
 
   
 
2.85 
 
 
0.096 <10 34 3.26 
(3.00-3.53) 
34 7.12  
(5.86-8.38) 
32 26.78  
(24.61-28.95) 
32 19.78  
(15.64-23.92) 
≥10 46 3.17 
(2.93-3.42) 
46 10.11  
(8.58-11.63) 
42 24.17  
(22.23-26.10) 
40 24.73  
(20.57-28.88) 
Smoking status    
 
0.91 0.142 
   
 
1.83 0.180 
   
 
0.01 
 
 
0.943 
   
 
1.52 
 
 
0.222 
Daily smoker 62 3.26 
(3.07-3.44) 
62 8.45  
(7.21-9.70) 
56 25.27  
(23.60-26.93) 
58 21.64  
(18.46-24.82) 
Non- / ex- / 
occasional smoker 
18 3.06 
(2.56-3.55) 
18 10.17  
(8.13-12.20) 
18 25.39  
(22.19-28.59) 
14 26.21  
(18.17-34.26) 
1 single-item scale of subjective health, range 1 (very poor) to 5 (very good) 2 Self-Administered Comorbidities Questionnaire, range 0 to 36 with higher scores indicating more comorbidities 3 8-item quality of life scale, 
range 8 to 40 with higher scores indicating better QoL 4 Employed / student / homemaker/ on temporary sick leave for under 3 months 5 Unemployed / on disability * < 0.05 ** < 0.01 *** < 0.001  
  
  
Table 3. Associations of variables with self-rated health, comorbidities and QoL in multivariate 
linear regression models. 
 Original data n=66  Pooled data n=80 
 
 Unstandardized 
coefficient B 
Std. 
Error 
p 
Adjusted  
R2 
Unstandardized 
coefficient B 
Std. 
Error 
p 
SAH1        
Male gender 0.368 0.183 0.048* 0.227 0.297 0.776 0.093 
Age -0.004 0.009 0.698 -0.005 0.177 0.534 
Secondary 
education or 
higher 
-0.020 0.194 0.920 0.003 0.009 0.987 
Employed -0.185 0.202 0.363 -0.182 0.179 0.369 
Alcohol as 
primary SUD 
-0.199 0.206 0.338 -0.119 0.202 0.559 
Longer 
duration of 
SUD 
0.003 0.011 0.796 0.000 0.203 0.984 
Current 
smoker 
-0.189 0.229 0.414 -0.057 0.011 0.794 
Severity of 
depressive 
symptoms 
-0.028 0.007 <0.001*** -0.026 0.218 0.001** 
SCQ2        
Male gender -0.916 1.049 0.674 0.223 -0.916 1.049 0.382 
Age 0.064 0.052 0.161 0.064 0.052 0.212 
Secondary 
education or 
higher 
-0.653 1.062 0.480 -0.653 1.062 0.538 
Employed 0.538 1.207 0.694 0.538 1.207 0.656 
Alcohol as 
primary SUD 
0.483 1.210 0.593 0.483 1.210 0.690 
Longer 
duration of 
SUD 
0.148 0.062 0.016* 0.148 0.062 0.017* 
Current 
smoker 
0.692 1.293 0.814 0.692 1.293 0.592 
Severity of 
depressive 
symptoms 
0.093 0.044 0.037* 0.093 0.044 0.032* 
EUROHIS-
QoL-83 
   
 
   
Male gender 2.483 1.215 0.046* 0.445 2.792 1.265 0.028* 
Age 0.022 0.065 0.729 0.051 0.062 0.415 
Secondary 
education or 
higher 
-0.297 1.346 0.826 -0.581 1.359 0.670 
Employed -1.876 1.320 0.161 -1.874 1.378 0.174 
Alcohol as 
primary SUD 
-2.415 1.407 0.091 -1.998 1.438 0.165 
Longer 
duration of 
SUD 
-0.064 0.081 0.431 -0.048 0.076 0.527 
Current 
smoker 
0.299 1.546 0.847 0.605 1.467 0.680 
Severity of 
depressive 
symptoms 
-0.314 0.050 <0.001*** -0.294 0.060 <0.001*** 
1 single-item scale of subjective health, range 1 (very poor) to 5 (very good)  
2 Self-Administered Comorbidities Questionnaire, range 0 to 36 with higher scores indicating more comorbidities 
3 8-item quality of life scale, range 8 to 40 with higher scores indicating better QoL 
* < 0.05 ** < 0.01 *** < 0.001 
  
  
Figure 1. Common comorbidities (reported by more than 10% of participants) of inpatients with SUDs according to 
the Self-reported Comorbidities Questionnaire (SCQ).
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